Line 254: | Line 254: | ||
</div> | </div> | ||
− | <h2 class="section-header">Faculty</h2> | + | <h2 class="section-header">Faculty and Instructors</h2> |
<div class="media"> | <div class="media"> | ||
<img class="align-self-center mr-3" src="https://static.igem.org/mediawiki/2017/3/3a/T--NYU_Abu_Dhabi--kourosh.jpg" alt="Generic placeholder image"> | <img class="align-self-center mr-3" src="https://static.igem.org/mediawiki/2017/3/3a/T--NYU_Abu_Dhabi--kourosh.jpg" alt="Generic placeholder image"> | ||
<div class="media-body"> | <div class="media-body"> | ||
− | <h5 class="mt-0"> | + | <h5 class="mt-0">Kourosh Salehi-Ashtianii</h5> |
Kourosh Salehi-Ashtiani received his Ph.D. in Cell and Molecular Biology from Northwestern University (Evanston, IL, USA). His group aims to define the metabolic potential of eukaryotic genomes and use this information to identify strategies for improving bioproduct production in algal systems, as well as to remediate metabolic perturbations associated with human disease states. He currently serves as an Associate Professor of Biology and as the Principal Investigator of the Laboratory of Algal, Synthetic, and Systems Biology at NYUAD. | Kourosh Salehi-Ashtiani received his Ph.D. in Cell and Molecular Biology from Northwestern University (Evanston, IL, USA). His group aims to define the metabolic potential of eukaryotic genomes and use this information to identify strategies for improving bioproduct production in algal systems, as well as to remediate metabolic perturbations associated with human disease states. He currently serves as an Associate Professor of Biology and as the Principal Investigator of the Laboratory of Algal, Synthetic, and Systems Biology at NYUAD. | ||
</div> | </div> | ||
Line 266: | Line 266: | ||
<img class="align-self-center mr-3 reversed" src="https://static.igem.org/mediawiki/2017/4/4f/T--NYU_Abu_Dhabi--song.jpg" alt="Generic placeholder image"> | <img class="align-self-center mr-3 reversed" src="https://static.igem.org/mediawiki/2017/4/4f/T--NYU_Abu_Dhabi--song.jpg" alt="Generic placeholder image"> | ||
<div class="media-body reversed"> | <div class="media-body reversed"> | ||
− | <h5 class="mt-0"> | + | <h5 class="mt-0"> Yong-Ak (Rafael) Song</h5> |
Rafael Song received his Ph.D. in Biomedical Engineering from RWTH Aachen University (Aachen, Germany) and has worked at the Korea Institute of Science and Technology as a Senior Research Scientist. His lab is focused on applying microfluidics and nanofluidics to a broad range of bioscience challenges, targeting the interface between biology, physics and engineering. He is currently an Assistant Professor of Mechanical and Biomedical Engineering and as the Principal Investigator of the Micro- and Nanoscale Bioengineering Lab at NYUAD. | Rafael Song received his Ph.D. in Biomedical Engineering from RWTH Aachen University (Aachen, Germany) and has worked at the Korea Institute of Science and Technology as a Senior Research Scientist. His lab is focused on applying microfluidics and nanofluidics to a broad range of bioscience challenges, targeting the interface between biology, physics and engineering. He is currently an Assistant Professor of Mechanical and Biomedical Engineering and as the Principal Investigator of the Micro- and Nanoscale Bioengineering Lab at NYUAD. | ||
</div> | </div> | ||
Line 274: | Line 274: | ||
" alt="Generic placeholder image"> | " alt="Generic placeholder image"> | ||
<div class="media-body"> | <div class="media-body"> | ||
− | <h5 class="mt-0"> | + | <h5 class="mt-0"> Mazin Magzoub</h5> |
Mazin Magzoub received his Ph.D. in Biophysics from Stockholm University (Stockholm, Sweden) studying the biophysical properties of cell-penetrating peptides. His lab focuses on drug delivery strategies, amyloid diseases, and cancer therapeutics. He currently serves as an Assistant Professor of Practice in Biology and as the Principal Investigator of the Biophysics Lab at NYUAD. | Mazin Magzoub received his Ph.D. in Biophysics from Stockholm University (Stockholm, Sweden) studying the biophysical properties of cell-penetrating peptides. His lab focuses on drug delivery strategies, amyloid diseases, and cancer therapeutics. He currently serves as an Assistant Professor of Practice in Biology and as the Principal Investigator of the Biophysics Lab at NYUAD. | ||
</div> | </div> | ||
</div> | </div> | ||
− | + | <div class="media reversed"> | |
− | + | <img class="align-self-center mr-3 reversed" src="https://static.igem.org/mediawiki/2017/4/4f/T--NYU_Abu_Dhabi--ibrahim.jpg" alt="Generic placeholder image"> | |
− | + | <div class="media-body reversed"> | |
− | <div class="media"> | + | <h5 class="mt-0">Ibrahim Chehade</h5> |
− | <img class="align-self-center mr-3" src="https://static.igem.org/mediawiki/2017/4/4f/T--NYU_Abu_Dhabi--ibrahim.jpg" alt="Generic placeholder image"> | + | |
− | <div class="media-body"> | + | |
− | <h5 class="mt-0"> | + | |
Ibrahim Chehade received his M.Sc. in Integrative Biology at Wilfrid Laurier University (Waterloo, Ontario, Canada) in the field of Environmental Toxicology and Endocrinology. He currently serves as an Associate Instructor of Biology at NYUAD. | Ibrahim Chehade received his M.Sc. in Integrative Biology at Wilfrid Laurier University (Waterloo, Ontario, Canada) in the field of Environmental Toxicology and Endocrinology. He currently serves as an Associate Instructor of Biology at NYUAD. | ||
</div> | </div> | ||
</div> | </div> | ||
− | <div class="media | + | <div class="media"> |
− | <img class="align-self-center mr-3 | + | <img class="align-self-center mr-3" src="https://static.igem.org/mediawiki/2017/f/f5/MonaK.png" alt="Generic placeholder image"> |
− | <div class="media-body | + | <div class="media-body"> |
− | <h5 class="mt-0"> | + | <h5 class="mt-0"> Mona Kalmouni</h5> |
Mona pursued her M.Sc. in Biotechnology at McGill University in Montreal, Canada where she worked on assessing the effect of gold nanoparticles on glioblastoma cell viability and autophagy. She also received her M.Ed. from the Institute of Education UCL in London, UK while running an education center and carrying out various teaching duties. | Mona pursued her M.Sc. in Biotechnology at McGill University in Montreal, Canada where she worked on assessing the effect of gold nanoparticles on glioblastoma cell viability and autophagy. She also received her M.Ed. from the Institute of Education UCL in London, UK while running an education center and carrying out various teaching duties. | ||
Due to her passion in teaching and science, she joined NYU Abu Dhabi as an Associate Instructor of Biology for the Foundations of Science courses. She is also involved in a research project that focuses on cell-penetrating peptides as a potential therapeutic strategy in cancer. | Due to her passion in teaching and science, she joined NYU Abu Dhabi as an Associate Instructor of Biology for the Foundations of Science courses. She is also involved in a research project that focuses on cell-penetrating peptides as a potential therapeutic strategy in cancer. | ||
</div> | </div> | ||
</div> | </div> | ||
− | <div class="media"> | + | <div class="media reversed"> |
− | <img class="align-self-center mr-3" src="https://static.igem.org/mediawiki/2017/2/29/Ashleyisaac.jpeg" alt="Generic placeholder image"> | + | <img class="align-self-center mr-3 reversed" src="https://static.igem.org/mediawiki/2017/2/29/Ashleyisaac.jpeg" alt="Generic placeholder image"> |
− | <div class="media-body"> | + | <div class="media-body reversed"> |
− | <h5 class="mt-0"> | + | <h5 class="mt-0"> Ashley Isaac </h5> |
Ashley Isaac received his M.Sc. in Microbiology from the University of KwaZulu-Natal (Durban, South Africa) and has served as the LIMS Administrator at the HIV Prevention Research Unit. He currently serves as an Associate Instructor of Biology at NYUAD. | Ashley Isaac received his M.Sc. in Microbiology from the University of KwaZulu-Natal (Durban, South Africa) and has served as the LIMS Administrator at the HIV Prevention Research Unit. He currently serves as an Associate Instructor of Biology at NYUAD. | ||
</div> | </div> |
Revision as of 06:54, 30 October 2017